Literature DB >> 14727458

Colchicine-induced leukopenia in a patient with familial Mediterranean fever: the cause and a possible approach.

E Ben-Chetrit1, P Navon.   

Abstract

A young patient with familial Mediterranean fever (FMF) developed leukopenia each time she took colchicine. However, when she discontinued the drug the white cell and the platelets counts increased but she experienced FMF attacks. Later it was found that the patient also had concomitant cytomegalovirus (CMV) infection. This complex situation posed several diagnostic and therapeutic issues concerning the real cause for the leukopenia and the possible approach to take in such conditions. We propose that when an essential drug (such as colchicine for FMF) causes leukopenia, one should look for concurrent CMV or another viral infection. If there is no such infection, it is suggested that the mechanism leading to leukopenia be clarified. In the case of bone marrow suppression, colchicine should be continued with injections of G-CSF, whereas if the bone marrow is hypercellular it is suggested to use steroids and colchicine concomitantly.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14727458

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  4 in total

Review 1.  Colchicine for secondary prevention of cardiovascular disease.

Authors:  Stefan M Nidorf; John W Eikelboom; Peter L Thompson
Journal:  Curr Atheroscler Rep       Date:  2014-03       Impact factor: 5.113

2.  Two cases of acute leukopenia induced by colchicine with concurrent immunosuppressants use in Behçet's disease.

Authors:  Kyu-Yeop Lee; Do Young Kim; Jae Yong Chang; Dongsik Bang
Journal:  Yonsei Med J       Date:  2008-02-29       Impact factor: 2.759

3.  Risk of infections in patients with gout: a population-based cohort study.

Authors:  B Spaetgens; F de Vries; J H M Driessen; H G Leufkens; P C Souverein; A Boonen; J W M van der Meer; L A B Joosten
Journal:  Sci Rep       Date:  2017-05-03       Impact factor: 4.379

Review 4.  Familial Mediterranean Fever: Recent Developments in Pathogenesis and New Recommendations for Management.

Authors:  Seza Özen; Ezgi Deniz Batu; Selcan Demir
Journal:  Front Immunol       Date:  2017-03-23       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.